How will Unilever accelerate growth after its 2024 portfolio reset?
Unilever retooled its portfolio in 2023–2024, exiting ice cream and selling Elida Beauty to sharpen focus on Beauty & Wellbeing, Personal Care, Home Care and Nutrition. The strategy targets higher-margin categories, reinvestment in innovation and disciplined capital allocation to lift growth.
The Growth Action Plan centers on portfolio simplification, tech‑led innovation, and geographic expansion in faster-growing markets; see Unilever Porter's Five Forces Analysis for competitive context.
How Is Unilever Expanding Its Reach?
Primary customers include value‑seeking consumers in emerging markets and premium buyers in developed markets, with strong cohorts in personal care, beauty, and food categories across retail, e‑commerce and informal channels.
Geographic mix and emerging markets
More than 50% of group turnover is from emerging markets; India, China, Southeast Asia and Africa are core growth pillars with rural penetration and sachetization driving reach.
India performance (HUL)
Hindustan Unilever reported FY2024 sales above ₹60,000 crore (~€6.6–7.0b) with double‑digit underlying volume growth and distribution exceeding 9 million outlets.
Category focus & premiumization
Beauty & Wellbeing plus Personal Care account for roughly half of group turnover and deliver higher margins; prestige beauty targets mid‑teens growth with China/US and travel retail expansion.
Health & Wellbeing scaling
Science‑backed brands such as OLLY and Liquid I.V. are scaling in the US with international rollouts planned across 2024–2026 and product line extensions in hydration and women’s health.
Expansion also includes portfolio reshaping and route‑to‑market shifts to accelerate growth in higher‑margin segments.
Ice cream separation & capital reallocation
Announced March 2024, the ice cream separation aims for completion in 2025–2026 to free capital and management focus for faster‑growing, less capital‑intensive categories.
- Operational disentanglement and supply agreements are interim milestones
- Market‑testing strategic options and potential listings during 2025
- Expected to improve return on capital for remaining portfolio
- Will reduce exposure to low‑growth, high‑capex format
Product pipeline & brand renovation
Core brands are receiving science‑led upgrades and format innovation—concentrates, refills, solid formats—to improve mix and pricing power across key markets through 2025.
- Dove Hair Therapy and Dove Advanced Care expansions rolled out 2023–2025 in North America, Europe and LATAM
- Upgrades include microbiome‑friendly skin care, long‑lasting fragrances and cleaner labels
- Format innovations target cost‑per‑use and sustainability metrics
- Renovation supports premiumization in Beauty & Wellbeing and Home Care
Route‑to‑market and partnerships
Digital commerce, quick‑commerce tie‑ups and B2B platforms underpin last‑mile reach; many brands exceed 20–30% online sales mix in select markets.
- Quick‑commerce and marketplace partnerships accelerate penetration in urban areas
- B2B platforms expand distribution across Africa and South Asia
- Selective bolt‑on M&A in Prestige Beauty and Health & Wellbeing remains possible
- Divestments of sub‑scale assets continue; Elida signed 2024, closing expected 2025 subject to approvals
Sustainability‑linked growth
Plant‑based foods and regenerative agriculture programs are being expanded to meet retailer scorecards and gain shelf space in Europe and North America through 2026.
- Scale‑up of The Vegetarian Butcher and alternative‑protein SKUs
- Regenerative programs in Knorr and Hellmann’s supply chains to improve sourcing resilience
- Sustainability initiatives tied to commercial wins and retailer procurement criteria
- Expected to support both margin and volume growth as ESG demands rise
Further reading on strategic direction is available in the company chapter: Growth Strategy of Unilever
How Does Unilever Invest in Innovation?
Customers increasingly demand effective, sustainable, and digitally enabled products; Unilever responds with science-led personal care, low‑impact home and nutrition offerings, and DTC experiences that prioritize transparency and convenience.
R&D and Science Platform
Unilever allocates roughly 2% of turnover to R&D across 20+ global centres, prioritizing dermatology, hair biology, fermentation and flavor science.
Patent and Formulation Strengths
Patents in encapsulated fragrances and stain‑removal enzymes underpin Home Care leadership and defend pricing and margins.
Digital and AI Deployment
AI is used for demand forecasting, dynamic pricing and media optimisation, delivering sequential service level and marketing ROI gains since 2023.
Generative AI Pilots
Generative AI accelerates creative testing and claims substantiation, shortening concept‑to‑shelf cycles by months in select categories.
Manufacturing & Automation
Industry 4.0 rollouts in 250+ factories integrate IoT, predictive maintenance and energy optimisation; lighthouse sites report OEE improvements and mid‑single‑digit cost savings.
Sustainability Tech Scale-up
Cold‑wash detergents, ultra‑concentrates, PCR plastics and mono‑material packaging are scaled to meet 2025–2030 targets and improve online conversion via eco‑labels.
External Innovation & Commercialisation
Partnering with universities, biotech startups and packaging innovators accelerates enzyme‑based stain removal, biodegradable surfactants and post‑consumer resin integration; prestige and health brands leverage DTC stacks and subscriptions to lift repeat and LTV.
- R&D spend ~2% of turnover across 20+ labs
- 250+ factories with Industry 4.0, lighthouse sites achieving mid‑single‑digit cost savings
- Generative AI pilots reduce time‑to‑shelf by months in some categories
- Sustainability measures (PCR, mono‑material, concentrates) support 2025–2030 targets and retailer KPIs
For industry context and competitive benchmarking see Competitors Landscape of Unilever
What Is Unilever’s Growth Forecast?
Unilever operates across more than 190 countries with particularly strong positions in Europe, North America, South Asia and Latin America; emerging markets account for a material share of revenue, led by South Asia and Africa where rapid urbanisation and rising middle‑class penetration drive demand.
Recent performance (2024)
Turnover in 2024 was approximately €59–60 billion with underlying sales growth in the mid‑single digits, driven by price carryover and improving volumes; Beauty & Wellbeing and Personal Care outgrew the group average.
Margin and productivity
Underlying operating margin expanded in 2024 on productivity gains and favourable mix; management targets further margin progression in 2025 as reinvestment cadence and cost programmes crystallise.
Guidance and targets
Under the Growth Action Plan Unilever targets sustained mid‑single‑digit underlying sales growth (USG) and modest annual underlying operating margin (UOM) expansion, underpinned by portfolio mix shift and cost savings.
Ice cream separation impact
Planned ice cream separation is expected to be margin‑accretive to RemainCo post‑disentanglement, improving group focus on Beauty, Personal Care and Foods portfolios.
Capital allocation and balance sheet priorities reflect a mix of reinvestment, shareholder returns and disciplined M&A.
Capital allocation
Brand and R&D investment has increased, funded in part by gross savings programmes targeting 2–2.5% of sales and SKU simplification to free up spend for strategic growth.
Shareholder returns
Share buybacks and a progressive dividend policy continue, subject to leverage constraints; net debt remained manageable in 2024 with strong free cash flow conversion historically around 90–100% of underlying net profit.
Balance sheet flexibility
High FCF conversion provides flexibility for bolt‑on M&A in Prestige and Health & Wellbeing while maintaining investment-grade metrics.
Benchmarks vs peers
Premium beauty peers grow at high single to low double digits with higher margins; Unilever aims to narrow this gap via portfolio mix shift and brand premiumisation.
Emerging markets benchmark
Hindustan Unilever (HUL) EBIT margins north of 20% serve as a material internal benchmark supporting group margin aspirations in emerging markets.
Analyst expectations 2025
Analysts project 2025 USG in the 3–5% range with incremental 30–60 bps margin expansion, contingent on reinvestment cadence and execution of cost programmes.
2025 watchpoints for investors
Key near‑term variables that will shape the financial outlook include volume recovery breadth, normalization of price elasticity, input cost deflation versus currency headwinds, and successful execution of the ice cream separation.
- Monitor volume momentum across emerging markets and Europe
- Track input cost trends and currency translation effects on euro‑reported results
- Assess margin capture from productivity and SKU rationalisation
- Evaluate reinvestment rate into marketing, R&D and premiumisation
For a deeper look at Unilever target customer segments and market positioning see Target Market of Unilever.
What Risks Could Slow Unilever’s Growth?
Potential risks and obstacles for Unilever include intensified competition from local insurgents and global peers across skin care, hair care and hygiene, execution risks from the planned ice‑cream carve‑out, regulatory and ESG scrutiny, input cost and FX volatility, climate‑driven supply chain shocks, and rising data/technology risks that could weigh on margins and growth.
Competitive intensity
Local insurgent brands and direct‑to‑consumer challengers are fragmenting prestige and mass segments; failure to match pace of product innovation could erode share and pricing power.
Ice‑cream separation execution
Carve‑out complexity risks stranded costs, supply‑chain disentanglement and loss of scale benefits; value realization could slip into 2025–2026 if delays or weak markets occur.
Regulatory and ESG pressure
EU/UK/US packaging rules, HFSS restrictions and green‑claims enforcement raise reformulation and compliance costs and can constrain marketing in emerging markets.
Input cost and FX volatility
Volatile edible oils, surfactants and dairy (pre‑separation ice cream exposure) plus currency swings in Turkey, Nigeria and Argentina can compress margins despite pricing actions.
Supply chain and climate shocks
Extreme weather affecting tea, tomatoes and soybean oil and logistics disruptions increase cost and service risk; multi‑sourcing and resilience programs reduce but do not remove exposure.
Data, AI and cybersecurity risks
Digital acceleration raises AI governance, data privacy and cyber risk; existing risk frameworks and red‑team testing mitigate but residual vulnerabilities persist.
The combination of these risks could affect Unilever growth strategy and Unilever future prospects by pressuring margins, slowing market expansion initiatives and increasing capital allocated to compliance and resilience.
Regulatory cost impact
Reformulation and packaging compliance could add several hundred million euros of incremental cost annually in stricter markets based on 2024 regulatory trends.
Commodity sensitivity
Edible oil and dairy price swings historically accounted for material input inflation; hedging and pricing actions reduced but did not eliminate margin exposure in 2023–2024.
Separation timeline risk
Management targeted ice‑cream separation outcomes by 2025; execution slippage could push realization into 2026 and delay expected efficiency gains and proceeds.
Competition and innovation gap
Failing to match DTC, prestige or local brand innovation may reduce Unilever market expansion and erode market share in personal care and hygiene segments.
For further context on brand and marketing implications see Marketing Strategy of Unilever
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.